Admission condition: poor sleep, fatigue, backache, light urinary color, swelling around eyelids and low limbs, blood pressure: 160/100mmHg, heart rate: 88beats/min, serumcreatinine: 736umol/L, urea nitrogen: 22mmol/L, uric acid: 411mmol/L, clearance rate of endogenous creatinine: 18ml/L, hemachrome: 72g/L, size of red blood cell: 0.19l/L, urine protein: ++, occult blood: +, potassium: 5.94mmol/L, blood AB: 18mmol/L, size of left kidney: 9.5×4.7×3.5cm，size of right kidney: 9.6×4.8×3.5cm,
Diagnosis: Chronic Glomerulonephritis, Chronic Kidney Disease (stage 4), Renal Anemia, Renal Hypertension
Treatment: Patient received Micro-Chinese Medicine Osmotherapy for about two months and then received Immunotherapy for three times. Meanwhile, we offered her with some western medicines as assistant treatment. Later, symptoms of patient were relieved, so patient went back home to consolidate.
Two months later, patient went to local hospital to do examination: blood pressure: 120/80mmHg,
heart rate: 80beats/min, serum creatinine: 510umol/L, urea nitrogen: 11mmol/L, clearance rate of endogenous creatinine: 76ml/L, hemachrome: 118g/L, size of red blood cell: 0.35l/L, urine protein: +, occult blood: -, potassium: 4.5mmol/L, blood AB: 25mmol/L, size of left kidney: 9.0×4.0×3.5cm，size of right kidney: 9.1×4.2×3.5cm
Expert Comments:
Micro-Chinese Medicine Osmotherapy combines traditional Chinese medicine and modern device. With the help of device, effective ingredients in the medicine can get into renal lesions through meridiants. Some effective ingredients in Chinese medicines can activate damaged cells, so that these cells can play their function again. Moreover, by removing waste products, Chinese medicine can improve blood circulation, which makes the damaged intrinsic cells receive nutrient substances fluently. Thus, blood pressure of patient decreases.
Micro-Chinese Medicine Osmotherapy creates a fine internal environment for patients to receive Immunotherapy. Immunotherapy are a group of special cells which have a strong ability of generating daughter cells. When Immunotherapys are injected into patients’ body, these Immunotherapys will differentiate into new renal intrinsic cells to replace necrotic cell, so as to repair renal structure. Moreover, these Immunotherapys can release factors to stimulate damaged intrinsic cells, so that renal function can be recovered quickly.
The combination of these two treatments ensures the treatment effects. Moreover, because these two treatments can treat kidney disease fundemantly, patients’ disease will not relapse.
